News
-
-
PRESS RELEASE
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding change in shareholding. Oxurion specializes in acquiring majority stakes in European pharmaceutical subcontractors -
-
-
-
-
PRESS RELEASE
Oxurion bevestigt de vooruitgang van de onderhandelingen over haar strategie voor de diversificatie van de kasmiddelen; closing van de transactie wordt vóór 25 september 2025 verwacht
Oxurion NV (EURONEXT BRUSSEL: OXUR) kündigt positive Finanzierungsgespräche mit Atlas Special Opportunities an. Die Transaktion wird voraussichtlich vor dem 25. September 2025 abgeschlossen sein -
-
-
PRESS RELEASE
Oxurion Receives Transparency Notifications from UBS Group AG
Oxurion NV received transparency notifications from UBS Group AG regarding share holdings, in compliance with Belgian Transparency legislation. The company is a biopharmaceutical group focusing on therapeutic innovation and clinical research technologies